Division of Endocrinology, Metabolism and Lipids
The discipline of Endocrinology, Metabolism and Lipids arrives at this new century with increased importance. The U.S. population is experiencing significant advances in life expectancy - concomitantly, clinical scientists face new challenges for improving the quality of these extra years. Many of the diseases afflicting the aging population are metabolic in nature - including diabetes, obesity and osteoporosis. The Emory Division of Endocrinology, Metabolism and Lipids believes that understanding the molecular and cellular pathophysiology of endocrine and metabolic diseases will lead to improved diagnostic and therapeutic approaches for both inherited and acquired conditions.
The Emory Division of Endocrinology, Metabolism and Lipids is composed of clinical and basic research faculty with interests in all aspects of endocrinology. Clinical care is delivered at four hospitals as well as the Emory Clinic. Ongoing clinical investigations study osteoporosis, pituitary disorders, nutrition and diabetes.
Emory endocrinologists also perform basic research into osteoporosis, hyperparathyroidism, bone metabolism, gene therapy of diabetes, growth factor physiology, nutrition and neuroendocrinology that is supported by federal grants. The Endocrinology fellowship training program enrolls 4-5 fellows each year and is supported by federal grants as well as hospital funds.
Medicine Grand Rounds – Endocrinology: Sept. 15
2014-2015 Department of Medicine faculty recognitions
Emory study suggests 'food security' a factor in diabetic management among Latinos
Molecule from trees helps female mice only resist weight gain